Executive chairperson of Bengaluru-headquartered Biocon Ltd Kiran Mazumdar-Shaw said on Monday night that she has tested positive for COVID-19. Photograph: Kind courtesy @KiranShaw/Twitter......
Corporate donations worth thousands of crores to political parties through now-scrapped electoral bonds may have hit the headlines, but there were also 132 such bonds of just Rs 1,000 each bought......
With the Supreme Court directing that private labs should conduct coronavirus tests free of cost, many laboratories expect the government to "come up with modalities" so that they can sustain......
The actual coronavirus positive cases in the country will be at least four times the reported count, biotech entrepreneur Kiran Mazumdar-Shaw said on Thursday, citing large number of......
Leading biotech firm, Biocon Ltd, on Tuesday said it would invest $10 million (about Rs 45 crore) in the next 12 months to expand its facilities. "We are quadrupling our existing drug development......
India's biotechnology major Biocon Ltd, is all set to make its way to Pakistan's pharmaceutical market by 2008 with its oncology drug BIOMAb EGFR. Talking to Business Standard, Subir Basak, general......
Biocon said on Thursday it has inked an exclusive pact with US-based Mylan to develop and commercialise generic versions of its three insulin products.The Bengaluru-based firm has entered into a......
Bangalore-based Biocon Ltd and a US biotech firm Nobex Corporation will jointly develop an oral insulin product for the treatment of diabetes.The collaboration combines the peptide production......